Form 4: DENTSPLY SIRONA Director's Equity Transactions
Insider Transaction Report
DENTSPLY SIRONA Director Gregory T. Lucier reported new RSU and stock option grants, alongside a gift of RSUs to a family partnership.
Summary
- Director Gregory T. Lucier was granted 3,858 Restricted Stock Units (RSUs) of DENTSPLY SIRONA Inc. common stock on August 8, 2025.
- These RSUs vest in full one year from the grant date.
- Lucier also gifted 24,047 RSUs to a family partnership on August 8, 2025.
- The family partnership now indirectly beneficially owns these 24,047 RSUs.
- Additionally, Lucier was granted 17,200 stock options with an exercise price of $12.96 on August 8, 2025.
- These stock options vest in full one year from the grant date, on August 8, 2026, and expire on August 8, 2035.
- Following these transactions, Lucier directly holds 106,348.434 common shares and indirectly holds 24,047 common shares through a family partnership and 21,000 common shares through his IRA.
- Lucier also directly holds 17,200 stock options.
Sentiment
Score: 6
Explanation: The filing indicates new equity grants to a director, which is generally positive as it aligns management's interests with shareholders. However, a significant portion of RSUs were gifted to a family partnership, which is a neutral event from a market perspective but reduces direct holdings.
Positives
- Grant of 3,858 Restricted Stock Units (RSUs) to Director Gregory T. Lucier, aligning his interests with shareholder value.
- Grant of 17,200 stock options with an exercise price of $12.96, providing potential future upside for the director.
Negatives
- A direct disposition of 24,047 Restricted Stock Units (RSUs) by gifting them to a family partnership, reducing direct beneficial ownership.
Related Party Transactions
- Gift of 24,047 Restricted Stock Units (RSUs) by the reporting person to a family partnership, where the reporting person's spouse serves as general partner and a trust for the reporting person's benefit is a partner.
Stakeholder Impact
- Shareholders: The grant of new equity awards to a director aligns his interests with long-term shareholder value. The gifting of RSUs to a family partnership does not directly impact the company's outstanding shares or market capitalization.
Next Steps
- Vesting of 3,858 Restricted Stock Units on August 8, 2026.
- Vesting of 17,200 Stock Options on August 8, 2026.
- Potential exercise of stock options by August 8, 2035.
Key Dates
| Date | Description |
|---|---|
| 08/08/2025 | Date of grant for 3,858 Restricted Stock Units (RSUs) and 17,200 stock options, and date of RSU gift to family partnership. |
| 08/08/2026 | Vesting date for 3,858 Restricted Stock Units and 17,200 stock options. |
| 08/08/2035 | Expiration date for 17,200 stock options. |
| 08/12/2025 | Date the Form 4 was signed by Attorney-in-Fact for Gregory T. Lucier. |
Recommendation
holdThis Form 4 filing primarily details routine equity compensation grants and a personal transfer (gift) by a director. While the grants align the director's interests with the company's performance, there's no new fundamental information about the company's operations, financial health, or strategic direction to warrant a change in investment thesis. The transactions are expected disclosures for an insider.
Keywords
DENTSPLY SIRONA, XRAY, SEC Form 4, Insider Trading, Restricted Stock Units, Stock Options, Director Compensation, Equity Grant, Beneficial Ownership, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.